Researching COVID to enhance recovery (RECOVER) autopsy tissue pathology study protocol: Rationale, objectives, and design (2024)

Advanced Search

Andrea B. Troxel, View ORCID ProfileMarie-Abele C. Bind, View ORCID ProfileThomas J. Flotte, Carlos Cordon-Cardo, Lauren A. Decker, Aloke V. Finn, Robert F. Padera, View ORCID ProfileR. Ross Reichard, James R. Stone, Natalie L. Adolphi, Faye Victoria C. Casimero, John F. Crary, Jamie Elifritz, Arline Faustin, Saikat Kumar B. Ghosh, Amanda Krausert, View ORCID ProfileMaria Martinez-Lage, Jonathan Melamed, Roger A. Mitchell Jr., Barbara A. Sampson, View ORCID ProfileAlan C. Seifert, Aylin Simsir, Cheryle Adams, Stephanie Haasnoot, View ORCID ProfileStephanie Hafner, Michelle A. Siciliano, View ORCID ProfileBrittany B. Vallejos, View ORCID ProfilePhoebe Del Boccio, Michelle F. Lamendola-Essel, View ORCID ProfileChloe E. Young, View ORCID ProfileDeepshikha Kewlani, Precious A. Akinbo, View ORCID ProfileBrendan Parent, Alicia Chung, View ORCID ProfileTeresa C. Cato, Praveen C. Mudumbi, Shari Esquenazi-Karonika, Marion J. Wood, James Chan, Jonathan Monteiro, View ORCID ProfileDaniel J. Shinnick, Tanayott Thaweethai, Amber N. Nguyen, Megan L. Fitzgerald, Alice A. Perlowski, View ORCID ProfileLauren E. Stiles, Moira L. Paskett, Stuart D. Katz, Andrea S. Foulkes RECOVER Initiative

doi: https://doi.org/10.1101/2023.04.27.23289234

  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF

Abstract

Importance SARS-CoV-2 infection can result in ongoing, relapsing, or new symptoms or organ dysfunction after the acute phase of infection, termed Post-Acute Sequelae of SARS-CoV-2 (PASC), or long COVID. The characteristics, prevalence, trajectory and mechanisms of PASC are poorly understood. The objectives of the Researching COVID to Enhance Recovery (RECOVER) Tissue Pathology Study (RECOVER-Pathology) are to: (1) characterize prevalence and types of organ injury/disease and pathology occurring with PASC; (2) characterize the association of pathologic findings with clinical and other characteristics; (3) define the pathophysiology and mechanisms of PASC, and possible mediation via viral persistence; and (4) establish a post-mortem tissue biobank and post-mortem brain imaging biorepository.

Methods RECOVER-Pathology is a cross-sectional study of decedents dying at least 15 days following initial SARS-CoV-2 infection. Eligible decedents must meet WHO criteria for suspected, probable, or confirmed infection and must be aged 18 years or more at the time of death. Enrollment occurs at 7 sites in four U.S. states and Washington, DC. Comprehensive autopsies are conducted according to a standardized protocol within 24 hours of death; tissue samples are sent to the PASC Biorepository for later analyses. Data on clinical history are collected from the medical records and/or next of kin. The primary study outcomes include an array of pathologic features organized by organ system. Casual inference methods will be employed to investigate associations between risk factors and pathologic outcomes.

Discussion RECOVER-Pathology is the largest autopsy study addressing PASC among US adults. Results of this study are intended to elucidate mechanisms of organ injury and disease and enhance our understanding of the pathophysiology of PASC.

Clinicaltrials.gov number: NCT05292274

Competing Interest Statement

I have read the journal's policy and the authors of this manuscript have the following competing interests: Brendan Parent reports receiving a research gift from United Therapeutics.

Clinical Trial

Clinical Trial Registration: Unique identifier: NCT05292274? http://www.clinicaltrials.gov.

Clinical Protocols

https://recovercovid.org/sites/default/files/docs/Autopsy.Protocol.v2.0.pdf

Funding Statement

National Institutes of Health (NIH) Agreement OTA OT2HL161841 (ASF), OT2HL156812 (N/A), OT2HL161847-01 (SDK/ABT) https://www.nih.gov/ The funders did not and will not have a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Not Applicable

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

IRB: NYU Grossman School of Medicine

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Not Applicable

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Not Applicable

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Not Applicable

Data Availability

No datasets were generated or analysed during the current study. All relevant data from this study will be made available upon study completion.

Copyright

The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.

Back to top

PreviousNext

PostedMay 04, 2023.

Download PDF

Data/Code

Email

Citation Tools

  • Facebook Like
  • Google Plus One

Subject Area

  • Pathology

Subject Areas

All Articles

  • Addiction Medicine (326)

  • Allergy and Immunology (641)

  • Anesthesia (170)

  • Cardiovascular Medicine (2451)

  • Dentistry and Oral Medicine (299)

  • Dermatology (208)

  • Emergency Medicine (384)

  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (866)

  • Epidemiology (11893)

  • Forensic Medicine (10)

  • Gastroenterology (707)

  • Genetic and Genomic Medicine (3824)

  • Geriatric Medicine (356)

  • Health Economics (646)

  • Health Informatics (2467)

  • Health Policy (953)

  • Health Systems and Quality Improvement (921)

  • Hematology (348)

  • HIV/AIDS (806)

  • Infectious Diseases (except HIV/AIDS) (13420)

  • Intensive Care and Critical Care Medicine (775)

  • Medical Education (379)

  • Medical Ethics (105)

  • Nephrology (409)

  • Neurology (3588)

  • Nursing (201)

  • Nutrition (536)

  • Obstetrics and Gynecology (692)

  • Occupational and Environmental Health (675)

  • Oncology (1863)

  • Ophthalmology (543)

  • Orthopedics (227)

  • Otolaryngology (293)

  • Pain Medicine (235)

  • Palliative Medicine (68)

  • Pathology (457)

  • Pediatrics (1056)

  • Pharmacology and Therapeutics (433)

  • Primary Care Research (431)

  • Psychiatry and Clinical Psychology (3241)

  • Public and Global Health (6254)

  • Radiology and Imaging (1316)

  • Rehabilitation Medicine and Physical Therapy (765)

  • Respiratory Medicine (842)

  • Rheumatology (387)

  • Sexual and Reproductive Health (382)

  • Sports Medicine (331)

  • Surgery (417)

  • Toxicology (51)

  • Transplantation (177)

  • Urology (149)

Researching COVID to enhance recovery (RECOVER) autopsy tissue pathology study protocol: Rationale, objectives, and design (2024)

References

Top Articles
Latest Posts
Article information

Author: Golda Nolan II

Last Updated:

Views: 6432

Rating: 4.8 / 5 (58 voted)

Reviews: 81% of readers found this page helpful

Author information

Name: Golda Nolan II

Birthday: 1998-05-14

Address: Suite 369 9754 Roberts Pines, West Benitaburgh, NM 69180-7958

Phone: +522993866487

Job: Sales Executive

Hobby: Worldbuilding, Shopping, Quilting, Cooking, Homebrewing, Leather crafting, Pet

Introduction: My name is Golda Nolan II, I am a thoughtful, clever, cute, jolly, brave, powerful, splendid person who loves writing and wants to share my knowledge and understanding with you.